The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yunilaynen O.A.

Mental Health Research Center

Baranov P.A.

Mental Health Research Center

Starostina E.G.

Vladimirsky Moscow Regional Research Clinical Institute

Przhiyalkovskaya E.G.

National Medical Research Center of Endocrinology

Zozulya S.A.

Mental Health Research Center

Ottman I.N.

Mental Health Research Center

Oleichik I.V.

Mental Health Research Center

Functional hypercortisolism in mental disorder — association with psychopathological manifestations and course of the disease

Authors:

Yunilaynen O.A., Baranov P.A., Starostina E.G., Przhiyalkovskaya E.G., Zozulya S.A., Ottman I.N., Oleichik I.V.

More about the authors

Read: 2670 times


To cite this article:

Yunilaynen OA, Baranov PA, Starostina EG, Przhiyalkovskaya EG, Zozulya SA, Ottman IN, Oleichik IV. Functional hypercortisolism in mental disorder — association with psychopathological manifestations and course of the disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3):130‑136. (In Russ.)
https://doi.org/10.17116/jnevro2024124031130

Recommended articles:

References:

  1. Zhdanava M, Pilon D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82(2):20m13699. https://doi.org/10.4088/JCP.20m13699
  2. Boschloo L, Hieronymus F, Lisinski A, et al. The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Transl Psychiatry. 2023;13(1):19.  https://doi.org/10.1038/s41398-022-02285-2
  3. Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder—translating findings from humans to animal models and back. Front Psychiatry. 2020;10:974.  https://doi.org/10.3389/fpsyt.2019.00974
  4. Kas’janov ED, Mazo GJe. Functioning of the hypothalamic-pituitary-adrenal axis in depression: the current state of the problem. Mental Health. 2017;15(8):27-34. (In Russ.).
  5. Herbert J. Cortisol and depression: Three questions for psychiatry. Psychological Medicine. 2013;43(3):449-469.  https://doi.org/10.1017/S0033291712000955
  6. Bobrov AE, Starostina EG, Alexandrova MM, et al. Mental disorders in patients with hormone-active pituitary adenomas. Social and Clinical Psychiatry. 2018;28(4):5-10. (In Russ.).
  7. Ynilaynen OA, Starostina EG, Dzeranova LK, et al. Epidemiology, diagnosis and treatment of hyperprolactinemia associated with the use of antipsychotics. RMJ. 2017;1:30-36. (In Russ.).
  8. Gorobets LN, Bulanov VS, Litvinov AV, Mazo GE. Modern views on the diagnosis of neuroleptic hyperprolactinemii. Russian Psychiatric Journal. 2018;(4):56-63. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.